Lilly (LLY) and Loxo Oncology (LOXO) Announce Expiration of HSR Act Waiting Period for Proposed Transaction

February 1, 2019 6:49 AM
Eli Lilly and Company (NYSE: LLY) (“Lilly”) and Loxo Oncology, Inc. (NASDAQ: LOXO) (“Loxo Oncology”) today announced the expiration of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles